Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Siaglide-M OD 100/1000 Tablet PR

Prescription Icon
Prescription Required

Marketer

Abbott

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Siaglide-M OD 100/1000 Tablet PR

Combiflex-DM 100/1000 tablets are a dual-action medication managing elevated blood glucose in patients with type 2 diabetes. This helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. Combiflex-DM 100/1000 may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes management; lifestyle choices significantly impact control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication isn't universally suitable. Prior to commencing treatment, inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or excessive alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Interactions with other medications are possible; disclose all current medications for safety assessment. Alcohol consumption should be minimized due to its hypoglycemic effect. Your physician will monitor kidney function and blood glucose levels throughout the treatment period.

Uses of Siaglide-M OD 100/1000 Tablet PR

Managing type 2 diabetes

Major Benefits of Siaglide-M OD 100/1000 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Siaglide-M OD 100/1000 Tablet PR with a meal.

Common Side effects of Siaglide-M OD 100/1000 Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Siaglide-M OD 100/1000 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Ingest Siaglide-M OD 100/1000 Tablet PR with a meal.

How Siaglide-M OD 100/1000 Tablet PR works:

Siaglide-M 100/1000 PR tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action optimizes blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Siaglide-M OD 100/1000 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Siaglide-M OD 100/1000 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Siaglide-M OD 100/1000 Tablet PR while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Siaglide-M OD 100/1000 Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is recommended. Siaglide-M OD 100/1000 Tablet PR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The use of Siaglide-M OD 100/1000 tablets is potentially hazardous for individuals with hepatic impairment and is best avoided. Medical advice is recommended.

What if you forget to take Siaglide-M OD 100/1000 Tablet PR :

Should you forget a Siaglide-M OD 100/1000 Tablet PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Siaglide-M OD 100/1000 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Siaglide-M OD 100/1000 Tablet PR

Siaglide-M OD 100/1000 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. It enhances blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Prolonged use of Siaglide-M OD 100/1000 Tablet PR can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Siaglide-M OD 100/1000 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Siaglide-M OD 100/1000 Tablet PR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siaglide-M OD 100/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Siaglide-M OD 100/1000 Tablet PR) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Siaglide-M OD 100/1000 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Siaglide-M OD 100/1000 Tablet PR commonly causes hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Siaglide-M OD 100/1000 Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Siaglide-M OD 100/1000 Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Siaglide-M OD 100/1000 Tablet PR) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Siaglide-M OD 100/1000 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Siaglide-M OD 100/1000 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It is not suitable for individuals under 18.
Siaglide-M OD 100/1000 Tablet PR may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Siaglide-M OD 100/1000 Tablet PR is contraindicated in patients allergic to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siaglide-M OD 100/1000 Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Siaglide-M OD 100/1000 Tablet PR) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Siaglide-M OD 100/1000 Tablet PR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Siaglide-M OD 100/1000 Ta...
388